by s2desi5_ksqtherapeutics | May 20, 2024
Michal Besser, PhD, is a global expert in immunology, cell therapy, and translational medicine, boasting an 18-year career spanning both academia and industry. Michal serves as Chief Technology Officer at the Davidoff Comprehensive Cancer Center, Rabin Medical Center,...
by s2desi5_ksqtherapeutics | May 20, 2024
Jason Bock, PhD, is a biotech leader with a track record of building organizations that translate cutting-edge science into impactful biologic therapies. In 2019, he joined MD Anderson to establish the Biologics Development group, an internal biotech initiative...
by s2desi5_ksqtherapeutics | May 20, 2024
Shari Pilon-Thomas PhD is a Senior Member of the Immunology Department and Co-Director of the Center for Immunization and Infection Research in Cancer (CIIRC) at Moffitt Cancer Center. She currently serves as the Co-Chair of the SITC Cell Therapy Committee. She...
by s2desi5_ksqtherapeutics | May 20, 2024
Chantale Bernatchez, Ph.D., is Head of Process Development at CTMC. With more than 20 years of experience in the fields of immunology and T-cell therapy, Dr. Bernatchez has been instrumental in advancing academic and biotechnology work in TIL (tumor-infiltrating...
by s2desi5_ksqtherapeutics | May 20, 2024
Kathy Seidl is an experienced drug discovery scientist with over 20 years experience in immunotherapeutics of varied modality applied to oncology and autoimmune indications. Kathy joined Takeda in December 2020, and since August 2021 has taken on the role of VP, Head...
